REFERENCES
- Kempen JH, et al. Risk of immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis. Ophthalmology. 2006; 113(4): 684–694.
- Thorne, J.E., et al. Incidence of and risk factors for visual acuity loss among patients with AIDS and cytomegalovirus retinitis in the era of highly active antiretroviral therapy. Ophthalmology. 2006; 113(8): 1432–1440.
- Robinson, M.R., et al. Immune-recovery uveitis in patients with cytomegalovirus retinitis taking highly active antiretroviral therapy. Am J Ophthalmol. 2000; 130(1): 49–56.
- Nguyen, Q.D., et al. Immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis after highly active antiretroviral therapy. Am J Ophthalmol. 2000; 129(5): 634–639.
- Thorne, J.E., et al. Causes of visual acuity loss among patients with AIDS and cytomegalovirus retinitis in the era of highly active antiretroviral therapy. Ophthalmology. 2006; 113(8): 1441–1445.
- Zafirakis, P., et al. Cystoid macular edema in a patient with acquired immunodeficiency syndrome and past ocular history of cytomegalovirus retinitis after initiation of protease inhibitors. Doc Ophthalmol. 1999; 97(3-4): 311–315.
- Anglade, E, Whitcup SM. The diagnosis and management of uveitis. Drugs. 1995; 49(2): 213–223.
- Aukrust P, Moum B, Farstad IN, Holter E, Bjorneklett A,Kremer D. Fatal. Cytome-galovirus (CMV) colitis in a patient receiving low dose prednisolone therapy. Scand J Infect Dis. 1991; 23: 495–499.
- Hsu, J., Drug delivery methods for posterior segment disease. Curr Opin Ophthalmol. 2007; 18(3): 235–239.
- Nguyen QD, Callanan D, Dugel P, Godfrey DG, Goldstein DA, Wilensky JT.Treating chronic noninfectious posterior segment uveitis: the impact of cumulative damage. Proceedings of an expert panel roundtable discussion. Retina. 2006; Suppl:1–16.
- Holland, G.N., AIDS and ophthalmology: the first quarter century. Am J Ophthalmol. 2008; 145(3): 397–408.
- Goldberg, D.E., et al., HIV-associated retinopathy in the HAART era. Retina. 2005; 25(5): 633–49; quiz 682–683.
- Raina, J., Bainbridge JW, Shah SM. Decreased visual acuity in patients with cytomegalovirus retinitis and AIDS. Eye. 2000; 14 (Pt 1): 8–12.
- Morrison, V.L., et al. Intravitreal triamcinolone acetonide for the treatment of immune recovery uveitis macular edema. Ophthalmology. 2007; 114(2): 334–339.
- Morrison, V.L., et al. Intravitreal toxicity of the kenalog vehicle (benzyl alcohol) in rabbits. Retina. 2006; 26(3): 339–344.
- Jaffe, G.J., et al. Fluocinolone acetonide implant (Retisert) for noninfectious posterior uveitis: thirty-four-week results of a multicenter randomized clinical study. Ophthalmology. 2006; 113(6): 1020–1027.
- Montero, J.A, Ruiz-Moreno JM. Intravitreal inserts of steroids to treat diabetic macular edema. Curr Diabetes Rev. 2009; 5(1):26–32.
- Ramchandran, R.S., et al. Fluocinolone acetonide sustained drug delivery device for chronic central retinal vein occlusion: 12-month results. Am J Ophthalmol. 2008; 146(2): 285–291.
- Ufret-Vincenty, R.L., et al. Cytomegalovirus retinitis after fluocinolone acetonide (Retisert) implant. Am J Ophthalmol. 2007; 143(2): 334–335.
- Delyfer MN, et al. Cytomegalovirus retinitis following intravitreal injection of triamcinolone: report of two cases. Acta Ophthalmol Scand. 2007;85(6):681–683.